Literature DB >> 20703287

Which way for genetic-test regulation? Leave test interpretation to specialists.

Arthur L Beaudet1.   

Abstract

Mesh：

Year:  2010        PMID： 20703287     DOI： 10.1038/466816a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  1 in total

1.  ACMG statement on direct-to-consumer genetic testing.

Authors: 
Journal:  Genet Med       Date:  2004 Jan-Feb       Impact factor: 8.822
  1 in total
  11 in total

1.  Improved access to life insurance after genetic diagnosis of familial hypercholesterolaemia: cross-sectional postal questionnaire study.

Authors:  Roeland Huijgen; Sietske J M Homsma; Barbara A Hutten; Iris Kindt; Maud N Vissers; John J P Kastelein; Jan L A van Rijckevorsel
Journal:  Eur J Hum Genet       Date:  2012-02-01       Impact factor: 4.246

2.  Neither as harmful as feared by critics nor as empowering as promised by providers: risk information offered direct to consumer by personal genomics companies.

Authors:  Anders Nordgren
Journal:  J Community Genet       Date:  2012-04-05

3.  Consumers have a right to affordable genetic testing.

Authors:  Christopher Kanan
Journal:  Nature       Date:  2010-08-26       Impact factor: 49.962

4.  Understanding FDA regulation of DTC genetic tests within the context of administrative law.

Authors:  Jennifer K Wagner
Journal:  Am J Hum Genet       Date:  2010-10-08       Impact factor: 11.025

Review 5.  Direct-to-consumer personalized genomic testing.

Authors:  Cinnamon S Bloss; Burcu F Darst; Eric J Topol; Nicholas J Schork
Journal:  Hum Mol Genet       Date:  2011-08-09       Impact factor: 6.150

Review 6.  Risk factors for autism: translating genomic discoveries into diagnostics.

Authors:  Stephen W Scherer; Geraldine Dawson
Journal:  Hum Genet       Date:  2011-06-24       Impact factor: 4.132

7.  Maps for the world of genomic medicine: the 2011 CSHL Personal Genomes meeting.

Authors:  Xiangqun Zheng-Bradley; Paul Flicek
Journal:  Hum Mutat       Date:  2012-04-16       Impact factor: 4.878

8.  FDA's Proposed Guidance for Laboratory Developed Tests: How Should Regulators Balance the Risks and Promise of Innovation in Clinical Genetics?

Authors:  Michelle Bayefsky; Benjamin E Berkman
Journal:  FDLIs Food Drug Policy Forum       Date:  2015-02-25

9.  Promoting appropriate genetic testing: the impact of a combined test review and consultative service.

Authors:  Carlos J Suarez; Linbo Yu; Natalie Downs; Helio A Costa; David A Stevenson
Journal:  Genet Med       Date:  2017-01-26       Impact factor: 8.822

10.  Quality assessment of the genetic test for familial hypercholesterolemia in the Netherlands.

Authors:  Iris Kindt; Roeland Huijgen; Marieke Boekel; Kristiaan J van der Gaag; Joep C Defesche; John J P Kastelein; Peter de Knijff
Journal:  Cholesterol       Date:  2013-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.